Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Torigen Announces Positive Results for Dogs Administered the Company’s Autologous Cancer Vaccine


News Image

Torigen Pharmaceuticals Inc., an animal health biologics company, today announced positive preliminary results supporting the therapeutic potential of the company’s experimental Autologous Cancer Vaccine for treating metastatic hemangiosarcoma (HSA) in dogs. HSA is an aggressive and ultimately fatal cancer that most commonly originates in a dog’s spleen.

Torigen’s experimental Autologous Cancer Vaccine is a form of active immunotherapy consisting of cells harvested from the patient’s own tumor making this a cancer-type agnostic treatment. The results have been published in BMC Veterinary Research, a leading veterinary journal.

“This is exciting news for veterinarians and dog owners alike,” said Dr. Michael Lucroy, Chief Medical Officer and Board-Certified Veterinary Oncologist. “These findings demonstrate the potential for an individualized immunotherapy approach in the management of advanced cancers, like hemangiosarcoma.”

The publication reported that Torigen’s Autologous Cancer Vaccine had an effect as an active form of immunotherapy based on in vitro results where it was shown to upregulate two important molecules for generating an immune response on antigen presenting cells: MHC-II and CD80. Retrospective analysis of outcomes was done for dogs with stage III HSA treated with surgery alone, surgery followed by maximum tolerated dose (MTD) chemotherapy, and surgery followed by Torigen’s Autologous Cancer Vaccine. The study revealed a greater than 3-fold increase in survival of the dogs treated with their Autologous Cancer Vaccine over those receiving surgery alone. The median survival time of the vaccinated dogs was the same as dogs treated with MTD chemotherapy, without reported adverse events. The 1-year survival rate was 12.5% for the vaccinated dogs compared with 0% for dogs treated with surgery alone or surgery followed by MTD chemotherapy.

Lucroy added, “immunotherapy with the adjuvanted autologous cancer vaccine is capable of up-regulating MHC-II and CD80 in cultured canine monocyte-derived cells, which are important stimulatory molecules in generating an immune response, and the vaccine improves survival time in dogs with metastatic (stage III) HSA when compared to surgical treatment alone.”

These findings set the stage for a prospective clinical trial beginning in 2021. Torigen’s Autologous Cancer Vaccine is currently available to veterinarians in the United States as an experimental therapeutic and is regulated by the USDA.

About Torigen’s Autologous Cancer Vaccine:

Torigen’s Autologous Cancer Vaccine is a form of active immunotherapy consisting of cells harvested from the patient’s own tumor making this a cancer-type agnostic treatment. This whole cell cancer vaccine is generated by a novel method to preserve tumor associated antigens (TAA), and then mixing the cellular material with immune adjuvants. The goal is to increase presentation of TAA to the immune system, thereby increasing activation of tumor-specific T cells. The result is an enhanced ability of the immune system to destroy cancer cells, stop or slow the growth of cancer cells, or delay metastasis which can improve patient survival.

About Torigen Pharmaceuticals, Inc.:

Torigen is a commercial-stage biopharma company founded as a spin-off from the University of Notre Dame in collaboration with Cook Biologics. The company is headquartered in Farmington, CT and holds multiple patents around the novel vaccine technology. To date, more than 800 dogs across the United States have been treated with their Autologous Cancer Vaccine.

The Torigen team is passionate about innovation and dedicated to developing safe, effective, and affordable treatments for companion animals with cancer, solving unmet needs for veterinarians and pet owners. For more information, please visit Torigen.com.

Share article on social media or email:

Generali Deutschland Adopts Binah.ai’s Video-Based Health and Wellness Monitoring Technology to Power Its New State-of-the-Art VitalSigns&Care Self-Monitoring App


Binah.ai, a leading provider of general health and wellness video-based monitoring tools powered by artificial intelligence (AI), today announced that Generali Deutschland, the German business unit of Europe’s largest insurance Group, has adopted its award-winning technology to launch a new mobile application. The application is called VitalSigns&Care, and will put cutting-edge technology at the service of customers’ preventive healthcare, thereby strengthening Generali’s role as their life-time partner.

Binah.ai’s technology will run through the Generali Deutschland app, allowing users to extract vital parameters that are key to one’s health status such as heart rate, oxygen saturation, respiration rate and heart rate variability through the camera on their smartphone. In cooperation with global consulting firm, SDG Group, Generali Deutschland will complement Binah.ai’s technology with additional access to a vast range of assistance and prevention services. The Generali app highlights the importance of prevention in healthcare, hugely heightened by the current COVID-19 pandemic, and will include additional tailor-made optional services such as useful advice on nutrition, preventive healthcare and work-life balance.

“The adoption of our technology by a leader like Generali in the insurance industry is a significant seal of approval around our vision for Binah.ai,” said David Maman, Co-Founder and CEO of Binah.ai. “The German market is at the forefront of healthcare’s digital transformation, and we look forward to witnessing the many advantages that our vital signs monitoring capabilities can provide to those who access the application.”

Binah.ai’s award-winning technology applies a unique mix of signal processing and artificial intelligence technologies to extract and analyze a video stream taken from the upper cheek region of a human face, and then converts it into medical-grade accurate vital signs measurements.

“We will introduce a disruptive innovation in the field of insurance for preventive healthcare and assistance,” said Giovanni Liverani, CEO of Generali Deutschland. “As a trail-blazer in the global insurance market, Generali Deutschland will launch Generali VitalSigns&Care, a state-of-the-art app available for download on anyone’s smartphone and capable of testing – just by using the camera – important vital parameters as well as enabling users to access assistance and prevention services when needed. With this new digital solution, we put advanced analytics and Artificial Intelligence to the service of our customers, in a way that is affordable, fast and easy. A new tool to promote prevention, which, as we learnt during the current Covid emergency, is of paramount importance, and to protect our customer’s life and health.”

“I am really proud to see that even in the unprecedented time we are living right now, we have been able to collaborate with Generali on a real extraordinary project. This project is a unique innovation in the field of digital preventive healthcare and artificial intelligence. Our partnership with Generali is fully aligned with our mission – inspiring innovation and supporting our clients, their clients and the whole community by taking full advantage of the advanced analytics.”said Luca Quagini, CEO of SDG Group.

The app is expected to be available to German users via app stores in early 2021, with Generali exploring future options to extend the geographic scope to other markets.

For the Generali Deutschland press release, please go to: https://www.generali.com/media/News/Generali-VitalSigns-Care–the-new-app-that-puts-technology-to-the-service-of-preventive-healthcare

About Binah.ai

Binah.ai’s award-winning technology delivers on the company’s vision and mission to allow for basic and universally accessible health and wellness services for everyone, anywhere. We are accelerating the digital transformation of healthcare and wellness by converting any smartphone, tablet or laptop into a vital signs monitoring tool, delivered with medical-grade accuracy. Binah.ai’s technology has countless use cases that span fields including telemedicine, remote patient monitoring, primary care, personal and corporate wellness, preventive medicine, virtual trials, nursing homes, insurance, in-car wellness and many more. Our technology is in use with leading global organizations that understand that latest technologies and connected services are the roadmap to personalized, streamlined, and universally accessible health services that empower both organizations, and personal users.

The solution is not a medical device and should be considered as a self-assessment tool only.

Share article on social media or email:

The Dentists at Creekwood Dental Arts Celebrate 10 Years Providing Leading Dental Care in Waco, TX


The Dentists and Team at Creekwood Dental Arts in Waco, TX.

Creekwood Dental Arts Celebrate 10 Years of Providing Dental Care to Waco, TX.

Dentists Dr. Donna Miller, Dr. Michelle Hinds, and Dr. Austin Green also offer a full range of cosmetic dentistry services, tooth replacement options including dental implants and dentures, as well as state-of-the-art laser dentistry to treat gum disease.

Creekwood Dental Arts is proud to be celebrating 10 years in practice, providing patients of all ages with compassionate, expert dental care, including one-day dental implants. Their unwavering commitment to helping people maintain good oral health and beautiful smiles is reflected in numerous awards and glowing patient testimonials. For two years in a row, the practice has won the prestigious Locals Love Us Award for the Best Dentist in Waco, TX.

The family practice provides general dentistry including dental fillings for cavities, dental sealants, tooth extractions, root canals, and noninvasive therapies for temporomandibular joint (TMJ) disorder and sleep apnea. Dentists Dr. Donna Miller, Dr. Michelle Hinds, and Dr. Austin Green also offer a full range of cosmetic dentistry services, tooth replacement options including dental implants and dentures, as well as state-of-the-art laser dentistry to treat gum disease.

For those with missing teeth or teeth that are beyond repair, Teeth-in-a-Day™ enables patients to receive dental implants in just one day versus waiting months to be fitted for restorations. In the last 10 years, countless patients have benefited from this innovative technology, leaving the office the same day they came in—with better functioning teeth and improved confidence. Combining their skills as cosmetic dentists with dental implant training and experience, the Creekwood Dental Arts dentists are able to provide new smiles for their patients in the convenience of one office location.

While patient safety has always been a priority, the practice has taken extra steps in response to the coronavirus pandemic. They follow infection control recommendations from the ADA, CDC, and OSHA, with strict sanitization protocols implemented throughout the office. In addition, patients can wait in their car until a room is ready and temperatures are taken upon entry.

Drs. Miller, Hinds, and Green extend their gratitude to their entire dental team and the many patients who made this milestone possible. They look forward to the next 10 years in practice. To learn more about dental implants or any of the dental services performed by this experienced team of dentists in Waco, TX, visit CreekwoodDentalArts.com or call their office at 254-870-9026.

About Creekwood Dental Arts

Creekwood Dental Arts is a general dental practice offering personalized dental care to patients in Waco, Texas. Drs. Donna G. Miller, Michelle Hinds and Austin Green provide an array of services with state-of-the-art technology. Dr. Miller was voted the Texas Dentist of the Year™ from the Texas Academy of General Dentistry as well as accomplished The Mastership Award from the Academy of General Dentistry, the highest and most respected award in general dentistry. Creekwood Dental Arts is also an award-winning team, over the last two years they have received The Best Dentist Award by Locals Love Us Waco. To learn more about Drs. Miller, Hinds and Green or the services they offer, please visit their website at CreekwoodDentalArts.com or call 254-870-9026 to schedule an appointment.

Share article on social media or email:

SmartLinx Launches Five-Star Predictor that Enables Post-Acute Care Facilities to Improve Care and Quality Ratings for Staffing


The Five-Star Predictor helps care operators to predict and improve their Five-Star Quality Ratings for staffing.

SmartLinx Solutions, a leading provider of workforce management solutions dedicated to helping senior care providers navigate workforce challenges, including those stemming from COVID-19, today announced the SmartLinx Five-Star Predictor. The Five-Star Predictor gives long-term and post-acute care operators the power to proactively predict and improve their Five-Star Quality Ratings for staffing.

Staffing data comprises one of the three criteria the Centers for Medicare and Medicaid Services (CMS) uses to assign Five-Star Ratings to long-term care and post-acute care facilities. Ratings carry significant financial implications. The government bases per-patient Medicare reimbursements on the facility’s Five-Star Rating and distributes greater reimbursements to facilities with the highest ratings. Meanwhile, consumers, physicians, and financial institutions use the Five-Star Rating system to make informed decisions.

However, many facilities receive low Five-Star Ratings because they fail to meet CMS requirements for nursing care. The nursing shortage, high employee turnover, and sudden scheduling changes make meeting staffing requirements an ongoing challenge. Even before COVID-19, the senior care industry experienced 33% employee turnover each year, according to Argentum’s 2020 Workforce Trends Report. Skilled nursing facilities report even greater shortages.

A July 2019 study by Harvard and Stanford University revealed many facilities struggle to meet CMS staffing demands that require keeping a registered nurse (RN) onsite at least eight hours a day, including weekends. “One troubling aspect of our findings is that 75% of nursing homes were almost never in compliance with what CMS expected their RN staffing level to be, based on residents’ acuity,” wrote Fangli Geng, David Stevenson, and David Grabowski in Daily Nursing Home Staffing Levels Highly Variable, Often Below CMS Expectations for HealthAffairs.

The Growing Focus on Staffing Levels

The COVID-19 crisis has prompted new staffing requirements as well as renewed attention on nursing home staffing levels. For example, New Jersey recently passed a law that defines the certified nursing aides (CNAs) per patient ratio.

To accommodate new staffing regulations, operators need integrated scheduling and attendance software that can be easily adjusted. SmartLinx workforce management suite helps operators to effectively address these staffing challenges by creating schedules that support evolving federal and state requirements, tracking attendance against these levels, and quickly closing open shifts before they jeopardize staffing levels.

Key SmartLinx Five-Star Predictor Benefits

In addition to identifying staffing compliance issues before they manifest, SmartLinx Five-Star Predictor calculates each facility’s projected star rating for staffing in real-time. Providers learn what they must do to achieve their desired star rating weeks or months before the CMS reporting deadline. The Five-Star Predictor also delivers warnings when a facility’s staffing falls below their desired star rating’s requirements.

  • Better Five-Star Ratings: Predicts Five-Star Ratings for staffing on demand.
  • User-driven calculations: Enables users to choose their desired star rating and instructs them on the steps they need to take to achieve it.
  • Support for multiple facilities: Displays the status of multiple facilities on one unified dashboard and enables users to drill down to each facility’s data.
  • Responsive design: Allows users to access the tool in real-time on their mobile device.
  • Proactive warning messages: Displays warning messages when a facility falls below required staffing levels based on real-time scheduling, attendance, and Payroll-Based Journal data.

“We’re proud to release SmartLinx Five-Star Predictor to help skilled nursing providers deliver high quality care and reach their optimum rating,” said SmartLinx CEO Marina Aslanyan. “In skilled nursing, being able to predict and remediate staffing shortages and achieve their desired Five-Star Rating is essential to achieving business and quality care goals.”

Read more from Marina Aslanyan about the importance of Five-Star Ratings in a piece on McKnight’s Long-Term Care, here.

About SmartLinx

Founded in 2000 SmartLinx cares for those who care. Used in thousands of leading organizations, the SmartLinx solutions suite helps skilled nursing and senior care providers manage people and processes by harnessing the power of real-time data. Its solutions suite includes talent acquisition and onboarding, human resources, benefits and payroll, time & attendance, scheduling, compliance, and business analytics. New financing options with preferred third-party commercial lender Ascentium Capital provide several flexible structures and low introductory payment options to help clients utilize the breadth of SmartLinx’s capabilities and products. The company is headquartered in Iselin, New Jersey.

For more information, please visit http://www.smartlinxsolutions.com or call 877-501-1310.

Share article on social media or email:

IDbyDNA Receives Accreditation from College of American Pathologists (CAP)


News Image

“The value of an accreditation from CAP cannot be overstated for strengthening our positioning within our scientific community, as well as the business community and investors.”

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to IDbyDNA Inc., the company revolutionizing the use of metagenomics to improve health by decoding the unknown, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

The facility’s director, Robert Schlaberg, MD, PhD, MPH, was advised of this national recognition and congratulated for the excellence of the services being provided. IDbyDNA is one of more than 8,000 CAP-accredited facilities worldwide.

“This recognition further demonstrates our commitment to the highest levels of metagenomic testing,” said Dr. Schlaberg. “To be recognized for our excellence by the world’s largest organization of board-certified pathologists serves as another confirmation that we’re not only advancing our field with great work, but we’re also doing it the right way.”

IDbyDNA’s Chief Executive Officer, Guochun Liao, PhD, MBA, added, “The value of an accreditation from CAP cannot be overstated for strengthening our positioning within our scientific community, as well as the business community and investors. Third-party validation is of the utmost importance in the scientific community and we’re honored to receive it from CAP.”

The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.

During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

About IDbyDNA

IDbyDNA is revolutionizing the use of clinical metagenomics to improve health by decoding the unknown. IDbyDNA’s product suite delivers unparalleled data analytics and industry-leading expertise to support medical laboratories with actionable infectious disease testing and pathogen surveillance. By profiling tens of thousands of microorganisms from any specimen with a scalable and intuitive approach, IDbyDNA empowers healthcare providers with greater depth and transparency for better identification of pathogens in order to accelerate triage and treatment and improve public health. For more information, visit http://www.idbydna.com or reach out to us on Twitter, Facebook, LinkedIn, Vimeo or YouTube.

About the College of American Pathologists

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.

Share article on social media or email:



Updox Supports Healthcare Providers with Implementing Full Virtual Care Strategy; Boosts Staff Productivity by 30%


News Image

“Patients today are demanding faster, more convenient access to healthcare. That’s driving all practices, regardless of size, specialty, or location, to transform and modernize all aspects of care as patient preferences continue to shift,” said Michael Morgan, CEO, Updox.

Updox, the only place to manage healthcare communications across both in-person and virtual care, today released its Virtual Care Playbook: Four Steps to Connecting the Dots and Piecing Together Your Virtual Care Strategy. The COVID-19 pandemic has accelerated the consumerization of healthcare, and successful healthcare practices, health systems and pharmacies are not only implementing a variety of virtual care solutions to meet patient expectations, but are connecting the dots between them to create a streamlined virtual care experience. The Updox playbook — which comes on the heels of Updox’s Virtual Care Report and survey of more than 3,000 practices on their virtual care experiences — provides healthcare organizations with strategies on how to implement an effective virtual care strategy, sharing the real experiences of Updox customers.

Prior to the current public health crisis, the majority of patients reported being unhappy with their healthcare experiences. While many health systems and other healthcare organizations historically relied on the telephone or patient portals to communicate with patients, studies show almost 50% were not using portals to access their medical records. Considering this, as we move toward a post-COVID world, the practice of healthcare must be reinvented in order to increase patient satisfaction and engagement.

“Patients today are demanding faster, more convenient access to healthcare. That’s driving all practices, regardless of size, specialty, or location, to transform and modernize all aspects of care as patient preferences continue to shift,” said Michael Morgan, CEO, Updox. “While nearly 94% of practices have reported using telehealth as a result of the COVID-19 pandemic, it’s imperative that providers remember telehealth is just one piece of the puzzle. The next step is for all healthcare organizations to implement a custom virtual care strategy that is tailored to a practice’s specific needs to create the ideal experience for their patients. Our playbook collects best practices across the full scope of healthcare to help providers and make that process as seamless as possible.”

Seeking a way to save staff time and effort, Williamsburg Drug Co. adopted multiple Updox solutions — including Secure Text, Broadcast, Video Chat, and more — to ensure the pharmacy was running more efficiently. According to Adam Brown, CPhT, director of IT and CLIA Laboratory manager for Williamsburg Drug Company, “Everything we get from our individual Updox solutions add up to big savings. Leveraging Secure Text, for example, we have increased staff productivity by 30% while simultaneously reducing patient no-shows to zero. Utilizing electronic fax and forms has also made a world of a difference, as the pharmacy has saved roughly $1,000 a month on office supplies. Thanks to Updox, our pharmacy is more profitable and efficient than ever.”

Furthermore, Bridgeport Family Medicine headquartered in Tigard, Oregon, has experienced rapid growth since being founded roughly six years ago — even throughout the COVID-19 pandemic. With a staff of seven physicians serving more than 10,000 patients, the practice needed to implement innovative technology as it grew in order to continue delivering the deep personalized care its founders had always promised. With Electronic Fax, Bridgeport Family Medicine was able to alleviate the back-and-forth of a fax machine, saving up to $750 a month on the cost for hardware, phone lines, paper, toner, and shredding, while also reducing much of the administrative burden on its staff. Implementing Updox Video Chat, the practice was also able to continue serving its patients during the public health crisis without having to lay off staff.

To learn more about how Updox’s complete communication platform can enhance your patients’ experiences, boost office productivity, and drive organizational profitability, visit http://www.updox.com/healthcare-crm. To download the full Virtual Care Playbook and start connecting the dots and piecing together your own personalized virtual care strategy, click here.

About Updox

The only place to manage healthcare communications across both in-person and virtual care, Updox offers one consolidated inbox for healthcare providers to manage the entire patient journey and office productivity. Through an all-in-one platform, Updox provides a broad set of capabilities for virtual health, patient engagement, and paperless office efficiency that work together to reduce costs and drive revenue. Updox is integrated with more than 100 electronic health records (EHR) and pharmacy management systems and serves more than 560,000 users and 210 million patients. Updox customers also benefit from an engaged user community for benchmarking, idea exchange and networking. Learn how we simplify the business of healthcare. Visit http://www.updox.com or follow the company on Twitter, LinkedIn and Facebook.

Share article on social media or email:



Goliath Technologies Named A Top 10 Innovative Healthcare Company in 2020


Goliath Technologies Named Top 10 Innovative Healthcare Company of 2020

Goliath Technologies Named Top 10 Innovative Healthcare Company of 2020

“Goliath has been instrumental in changing the Health IT industry by empowering health systems to shift from reactive to proactive in regards to monitoring and troubleshooting clinician experience.” Alan Swann, CIOLook

60% of the largest health systems in the U.S. trust Goliath to improve patient care

Goliath Technologies, a leader in proactive end-user monitoring and troubleshooting software for Health IT, announced today that CIOLook, a global business authority for technology executives and entrepreneurs, named Goliath Technologies a Top 10 Innovative Healthcare Company in 2020. Their proven purpose-built technology enables IT to remove end-user experience performance barriers to improve patient care.

Goliath Technologies has become a standard in Health IT, with its technical and business relationships with all four major Electronic Health Record (EHR) providers (Cerner, Epic, MEDITECH, and Allscripts). Health systems can improve clinician experience by leveraging the performance metrics Goliath correlates into a single view from their EHR application, end-user experience, and their Citrix or VMware Horizon delivery infrastructure. IT Pros can then anticipate, troubleshoot, and document end-user experience issues more effectively to improve system performance for their medical staff.

Goliath Technologies has helped many health systems, including Universal Health Services, CommonSpirit Health, Ascension, NorthBay Healthcare, Inspira Health Network, Harnett Health, and Maimonides Medical Center. More healthcare providers are turning to Goliath to meet their clinician’s demand for always available, high-performing digital workspaces, EHR, and telehealth applications.

“We are honored to be named a Top 10 Innovative Healthcare Company in 2020,” said Thomas Charlton, CEO and Chairman, Goliath Technologies. “The COVID-19 crisis and corresponding burden it places on Health IT underscores, even more, the importance of technology that is purpose-built to solve the challenges inherent in supporting largely distributed workforces that are attempting to access critical applications using various devices and connection methods. At Goliath, we have developed technology with embedded intelligence and automation to discover, monitor, and troubleshoot clinician issues without the need for a group of expensive end-user experience IT professionals. Our clients report that the presence of our technology reduces the need for headcount and makes current IT staff more productive.”

What usually requires costly IT resources with very specific knowledge, Goliath accomplishes with software that has embedded intelligence and automation. This is critical because health IT usually has half the budgets and human resources as their enterprise counterparts to support the same number of users. Health systems can easily discover their entire Citrix or VMware Horizon environment and identify what to monitor, the thresholds to set, and then alert when thresholds are exceeded. The software does this for all potential events, conditions, and failure points regarding end-user performance issues when accessing and using their EHR systems along with other business and clinical applications.

“Selecting Goliath Technologies as a Top 10 Innovative Healthcare Company in 2020 was an easy choice,” said Alan Swann, CIOLook. “Goliath has been instrumental in changing the Health IT industry by empowering health systems to shift from reactive to proactive in regards to monitoring and troubleshooting clinician experience, which has made a significant impact on health systems’ performance and most importantly patient care.”

Learn how Goliath can offer value to your Health IT organization.

About Goliath Technologies

Goliath Technologies offers end-user experience monitoring and troubleshooting software, with embedded intelligence and automation, that enables IT pros to anticipate, troubleshoot, and document performance issues regardless of where workloads, applications, or users are located. By doing so, Goliath helps IT break out of reactive mode, and into proactive mode. Customers include Universal Health Services, Ascension, CommonSpirit, Penn National Insurance, American Airlines, Office Depot, Tech Mahindra, Pacific Life, Xerox, HCL, and others. Learn more about how we empower proactive IT at goliathtechnologies.com.

Share article on social media or email:

Dr. Julianne Arena first to bring Cliovana™ to Massachusetts


Dr. Arena first to bring Cliovana to Massachussets

A prominent leader in female health, Dr. Julianne Arena, of Waves of Awakening Center for Personalized Medicine, is adding this first-of-its-kind treatment for women to her integrative medical practice.

Waves of Awakening offers a personalized, integrative and functional approach to healthcare delivered by qualified, compassionate, and experienced providers. Their purpose is to provide patients the opportunity to improve their overall health and well-being.

Dr. Arena describes Waves of Awakening as a practice created by women warriors of healthcare and change. “I have always had an interest in the art as well as the science of healing. In May of 2016, I went to a conference on Integrative Medicine in Women’s Health. I could not believe there was so much out there that I hadn’t learned in conventional medical training to help my patients, my family and myself. My passion for healing was reignited and for me, there was no turning back.”

Cliovana is a simple, completely non-invasive way to increase women’s arousal levels and their orgasm frequency and intensity. Cliovana does not use lasers, scalpels or needles, so there are no dangerous side effects. Many women want to get more out of sex but they want to do it in a way that respects their body. Cliovana is the perfect solution because it enhances arousal at the cellular level, and causes your body to do more of what it does naturally – regenerate cells.

So how does Cliovana work? The body is always regenerating cells. Cliovana stimulates the body to do more of that, specifically in the genitals, and can lead to an increase in women’s long term sexual responsiveness. The technologies employed by Cliovana have been used for decades, all over the world, for a variety of health issues. The treatment is a total of four sessions at less than 10 minutes each, over the course of 2 weeks. Because it is 100% noninvasive, there is zero downtime.

Waves of Awakening is the first medical practice in Massachusetts to offer Cliovana treatments. Patients can find more information about the treatment as well as schedule a free consultation at https://www.cliovana.com

Learn more about Cliovana

https://cliovana.com

practitionerinfo@cliovana.com

1-888-583-5134

@cliovana

About Dr. Julianne Arena and Waves of Awakening Center for Personalized Medicine

Dr. Arena received her undergraduate degree at Harvard University and graduated from Boston University School of Medicine. She completed her residency in Obstetrics and Gynecology at Baystate Medical Center in Springfield MA. She then practiced conventional medicine as a board certified Ob/Gyn physician for 15 years before she had her own awakening.

Dr. Arena’s patient population includes young teens through and past menopause for well gynecology care and pap smears as well as those that want to address issues related to the thyroid, digestion, stress, infertility, weight, adrenals, hormone imbalance and sexual health.

Share article on social media or email:

Azalea Health Releases 2021 Predictions


News Image

The pandemic has put unprecedented pressure on the healthcare system, leading many providers to reevaluate their IT infrastructure…

Azalea Health, a leading provider of cloud-based patient management and health IT solutions, today announced their predictions for healthcare IT in 2021. Although some trends were already underway, the pandemic has been a catalyst for change as healthcare providers adapt to the new reality.

“The pandemic has put unprecedented pressure on the healthcare system, leading many providers to reevaluate their IT infrastructure,” said Baha Zeidan, CEO of Azalea Health. “We saw it first with the rapid adoption of telehealth, then with the urgent need for better data sharing to help providers coordinate their Covid-19 response. However, these trends will not end with the pandemic. We’re seeing an enduring transformation of healthcare’s relationship with IT.”

Zeidan predicts five key IT trends will drive change in healthcare in 2021:

Politics accelerate value-based care, and providers turn to data to improve outcomes.

Even if the Supreme Court overrules the ACA’s value-based care incentives, the trajectory towards value-based care is unlikely to change, the only question is how fast it will take over as the dominant reimbursement model. A Joe Biden administration will likely push for more capitation at the agency level, with the pace depending on who controls the Senate following runoff races in Georgia. To succeed under value-based care, providers will look for nimble EHR solutions that enable them to harness the intelligence of their patient data to improve outcomes.

On-premises Health IT infrastructure shifts to the cloud.

The shift to cloud-based EHR platforms will be driven by several factors. First, the financial pressures of the pandemic has led many providers to reevaluate the overhead costs of managing their IT infrastructure on-premises. Additionally, the cloud enables back-room functions to be done remotely, reducing the risk of Covid-19 exposure for staff and patients. Also, with the rise of ransomware, data breaches and other cyberattacks, providers will look to cloud-based EHR platforms to take the burden of security and compliance off their hands. Finally, cloud-based systems will enable providers to access patient data anywhere, enabling telehealth and better care coordination.

Interoperability becomes an essential capability for EHR platforms.

Although the ONC is close to finalizing and implementing its new interoperability standards for EHR vendors, the pandemic has brought into sharp relief the need for greater data sharing to track outbreaks, manage resources and coordinate care between health systems. Providers will look to adopt interoperable EHR systems before the new rules set in to connect to health information exchanges and ensure continuity of care. Another benefit of interoperability is that patients will have greater access to their health data. This will help healthcare to go touch free, replacing clipboards with mobile apps that speed up appointment times, reduce paperwork, and drive efficiency.

Telehealth becomes a permanent staple of healthcare.

The pandemic rapidly lowered the barriers to telehealth out of necessity. But now that everybody has tried it and seen its potential, it’s clear that telehealth will outlast the pandemic. Telehealth reimbursements will likely be expanded through 2021, as a hybrid model combining telehealth check-ins and in-person visits becomes the norm. This will save both providers and patients time on their appointments and open up more communication and engagement with patients. There will also be greater recognition of the needs of underserved communities, particularly those with limited access to transportation for whom telehealth will be a new lifeline of care, and those in rural areas where broadband access limits telehealth usage.

EHR adoption grows for behavioral health.

The pandemic has fueled a national mental health crisis, with 40.9% of Americans showing signs of adverse behavioral health conditions. Depression will manifest in higher rates of diabetes, obesity and heart problems as people reduce their physical activity. The connection between behavioral health and physical health will become more clear, and more providers and payers will recognize the importance of addressing behavioral health. EHR adoption, which has long lagged for behavioral health providers, will gain momentum as providers look to coordinate their behavioral health workflows with their physical health workflows.

About Azalea Health:

Azalea Health (Azalea) is changing the way health IT platforms connect community-based healthcare providers and patients across the care continuum. Offering a 100% cloud-based, interoperable solution, Azalea delivers electronic health records, revenue cycle management, and a fully integrated telehealth solution designed for rural, community and urban practices and hospitals, especially those focused on underserved populations. Quick to deploy and intuitive to use, Azalea solutions ensure better care coordination and communication, and the “one patient, one record” approach provides care teams the agility to achieve better outcomes. The Azalea platform also delivers tools and resources to help providers meet Meaningful Use requirements, and informs their strategies to navigate accountable care and alternative payment models.

Azalea Health PR Contact:

Lexi Herosian

lexi@scratchmm.com

Share article on social media or email:

Erchonia’s Published Peer-Reviewed Results Reveal Promising Treatment for Musculoskeletal Pain


~635 nm Red Laser~

Erchonia FX 635 Laser

Erchonia has dedicated the past 25 years to researching solutions for chronic pain. As rewarding as the FDA clearances have been, to now see the data combined into one research article puts into perspective what Erchonia has accomplished. This is the gold standard of laser therapy research.

Erchonia Corporation, the World Leader in low level laser technology, became the first and only laser to receive U.S. Food and Drug Administration (FDA) 510(k) clearance for the temporary relief of nociceptive musculoskeletal pain, in June 2019. 510(k) #K190572

The results of the clinical trials submitted to the FDA can now be found in the Orthopedics and Rheumatology Open Access Journal (Peer-reviewed Medical Journal). Article title “Efficacy of 635nm Red Low-Level Laser on Nociceptive Musculoskeletal Pain Compared to NSAIDS, Opioids, and Other Light Sources” Click Here for full article

The article includes data from (5) Level 1, double-blind, placebo-controlled clinical trials and (1) non-inferiority trial, with a total of 419 subjects. The assessed treatment areas include chronic neck and shoulder pain, low back pain and heel pain caused by plantar fasciitis.

Musculoskeletal diseases affect more than one out of every two people in the United States age 18 and over, and nearly three out of four age 65 and over. For those individuals, there is considerable impact on expense and daily life, as the yearly cost per patient with a musculoskeletal disease is $7,800 and nearly 364 million lost workdays, which is an average of 10 days per worker.

The most common treatment for musculoskeletal pain is Nonsteroidal anti-inflammatory drugs (NSAIDS). However due to side effects which attribute to as many as 107,000 hospitalizations and 16,500 deaths annually in the United States, the FDA states the use of NSAIDs should be used at the lowest effective amount for the shortest possible time. While short-term use of NSAIDs is appropriate in acute injuries, it is not an ideal treatment for chronic pain as the analgesic effect generally last no longer than 4-6 hours.

Erchonia provides an FDA cleared alternative, that is proven safe and effective. The substantial evidence which is now publicly available in the Open Access Journal, shows a reduction in pain of 45% directly following the Erchonia laser treatment(s). The results compare favorably to an article published in The Journal of the American Medical Association which showed NSAIDS and Opioids reduced chronic pain by 25% and 21% respectively. Remarkably, the pain relief provide by the Erchonia did not rapidly diminish, in fact following 2-4 months post treatment the pain reduction continued to improve to 61% and 73% at 12 months post.

Equally important as the reduction in pain, the published article documented changes in disability indexes; including the Oswestry Disability Index (ODI), which is considered the ‘gold standard’ for measuring disability and quality of life (QoL) impairment for adults with low back pain. In each condition treated there was a significant improvement in the patient’s disability, which can play a direct role in normal daily activities and returning to work.

The article also details the laser fundamentals (wavelength, power, coherence) that must be met to achieve an effective treatment. While other light/laser manufactures may erroneously claim the effectiveness for treating musculoskeletal pain, Erchonia is the only laser to provide blinded & controlled trials and receive FDA marketing clearance.

About Erchonia Corporation

Based in Melbourne, Florida, family-owned Erchonia is the global leader in the manufacturing and development of low-level laser therapy technology (“3LT”). From humble beginnings in a garage in 1996, Erchonia today develops and sells the most advanced, non-invasive 3LT medical equipment on the market in over 50 countries. In fact, Erchonia first low-level laser market clearance in 2002 prompted the FDA to create a new device category: NHN Biostimulation lasers. With 17 different market clearances from the FDA, Erchonia remains passionately committed to effective, research-based 3LT solutions for a wide variety of conditions — from managing chronic pain to promoting fat loss. For more information, please visit http://www.erchonia.com.

Share article on social media or email: